Publications by authors named "Tiffany Rodewald"

Claim this Profile
P
Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.
Zhibo An, Mary C Moore, Jason J Winnick, Ben Farmer, Doss W Neal, Tiffany Rodewald

Eur J Pharmacol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake.
Mary Courtney Moore, Catherine A Dicostanzo, Marta S Smith, Ben Farmer, Tiffany D Rodewald

Am J Physiol Endocrinol Metab· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.
Kathryn M S Johnson, Dale S Edgerton, Tiffany Rodewald, Melanie Scott, Ben Farmer

Am J Physiol Endocrinol Metab· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
Kathryn M S Johnson, Dale S Edgerton, Tiffany Rodewald, Melanie Scott, Ben Farmer

Am J Physiol Endocrinol Metab· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.
Noelia Rivera, Carrie A Everett-Grueter, Dale S Edgerton, Tiffany Rodewald, Doss W Neal

J Pharmacol Exp Ther· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis